| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 236 | 7.970 | 21.286 | 26.049 | 31.016 | 39.043 |
| Total Income - EUR | - | - | - | - | 236 | 7.970 | 21.286 | 26.049 | 31.016 | 39.044 |
| Total Expenses - EUR | - | - | - | - | 251 | 5.307 | 9.510 | 12.505 | 17.413 | 19.415 |
| Gross Profit/Loss - EUR | - | - | - | - | -15 | 2.663 | 11.776 | 13.544 | 13.603 | 19.630 |
| Net Profit/Loss - EUR | - | - | - | - | -22 | 2.432 | 11.189 | 12.880 | 11.470 | 16.552 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Cclinic Company S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 9.599 | 8.141 | 10.854 | 9.034 | 7.207 |
| Current Assets | - | - | - | - | 105 | 2.721 | 6.699 | 38.069 | 18.083 | 32.585 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 1.714 | 1.316 | 2.920 | 8.161 | 30.664 |
| Cash | - | - | - | - | 105 | 1.007 | 5.383 | 35.150 | 9.922 | 1.922 |
| Shareholders Funds | - | - | - | - | 28 | 2.460 | 13.727 | 26.649 | 11.518 | 16.600 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 77 | 9.860 | 1.113 | 22.274 | 15.599 | 23.253 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8695 - 8695" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Cclinic Company S.r.l.